Mapping intact mass proteoforms of Secukinumab by mass spectrometry

Key Points

• The research aims to identify and analyze the intact mass proteoforms of the drug Secukinumab.
• Utilized mass spectrometry techniques to profile proteoforms of Secukinumab.
• Conducted analyses to assess the immunobiological implications of identified proteoforms.
• Identified multiple proteoforms of Secukinumab with potential implications for immunobiological applications.

Abstract